Published in Nucleic Acids Res on October 01, 2003
The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol (2007) 6.16
Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics (2006) 5.59
Strengths and weaknesses of EST-based prediction of tissue-specific alternative splicing. BMC Genomics (2004) 2.74
Comparative analysis of transposed element insertion within human and mouse genomes reveals Alu's unique role in shaping the human transcriptome. Genome Biol (2007) 2.35
MATS: a Bayesian framework for flexible detection of differential alternative splicing from RNA-Seq data. Nucleic Acids Res (2012) 2.09
Function of alternative splicing. Gene (2012) 2.00
ECgene: genome-based EST clustering and gene modeling for alternative splicing. Genome Res (2005) 1.95
Evidence for a subpopulation of conserved alternative splicing events under selection pressure for protein reading frame preservation. Nucleic Acids Res (2004) 1.93
An expectation-maximization algorithm for probabilistic reconstructions of full-length isoforms from splice graphs. Nucleic Acids Res (2006) 1.90
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood (2012) 1.85
The ASAP II database: analysis and comparative genomics of alternative splicing in 15 animal species. Nucleic Acids Res (2006) 1.80
Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Oncogene (2007) 1.77
HOLLYWOOD: a comparative relational database of alternative splicing. Nucleic Acids Res (2006) 1.66
Evolution of SR protein and hnRNP splicing regulatory factors. Wiley Interdiscip Rev RNA (2011) 1.37
The importance of being divisible by three in alternative splicing. Nucleic Acids Res (2005) 1.29
Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays. BMC Genomics (2008) 1.25
A global view of cancer-specific transcript variants by subtractive transcriptome-wide analysis. PLoS One (2009) 1.23
Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene. FASEB J (2009) 1.23
Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack normal splice forms. Nucleic Acids Res (2005) 1.23
Homolog-specific PCR primer design for profiling splice variants. Nucleic Acids Res (2011) 1.19
Entropy measures quantify global splicing disorders in cancer. PLoS Comput Biol (2008) 1.18
The PRMT1 gene expression pattern in colon cancer. Br J Cancer (2008) 1.17
Aberrant RNA splicing and its functional consequences in cancer cells. Dis Model Mech (2008) 1.12
BAR the door: cancer suppression by amphiphysin-like genes. Biochim Biophys Acta (2008) 1.12
Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer. Oncogene (2010) 1.11
Peppy: proteogenomic search software. J Proteome Res (2013) 1.07
Predicting functional alternative splicing by measuring RNA selection pressure from multigenome alignments. PLoS Comput Biol (2009) 1.06
ECgene: an alternative splicing database update. Nucleic Acids Res (2006) 1.05
SERpredict: detection of tissue- or tumor-specific isoforms generated through exonization of transposable elements. BMC Genet (2007) 1.05
La enhances IRES-mediated translation of laminin B1 during malignant epithelial to mesenchymal transition. Nucleic Acids Res (2011) 1.03
High-throughput alternative splicing quantification by primer extension and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Nucleic Acids Res (2005) 1.02
An isoform of ZBP-89 predisposes the colon to colitis. Nucleic Acids Res (2006) 1.02
Alternative splicing: a potential source of functional innovation in the eukaryotic genome. Int J Evol Biol (2012) 1.00
WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear. Int J Oncol (2005) 0.99
Caffeine regulates alternative splicing in a subset of cancer-associated genes: a role for SC35. Mol Cell Biol (2007) 0.99
Non-EST based prediction of exon skipping and intron retention events using Pfam information. Nucleic Acids Res (2005) 0.97
Intron retention is a widespread mechanism of tumor-suppressor inactivation. Nat Genet (2015) 0.95
Functional characterization of alternatively spliced human SECISBP2 transcript variants. Nucleic Acids Res (2008) 0.95
Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression. J Clin Invest (2014) 0.93
Creation and disruption of protein features by alternative splicing -- a novel mechanism to modulate function. Genome Biol (2005) 0.89
RRP1B is a metastasis modifier that regulates the expression of alternative mRNA isoforms through interactions with SRSF1. Oncogene (2013) 0.88
A novel BAT3 sequence generated by alternative RNA splicing of exon 11B displays cell type-specific expression and impacts on subcellular localization. PLoS One (2012) 0.87
SplicerAV: a tool for mining microarray expression data for changes in RNA processing. BMC Bioinformatics (2010) 0.87
Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms. PLoS One (2013) 0.86
T-STAG: resource and web-interface for tissue-specific transcripts and genes. Nucleic Acids Res (2005) 0.86
Increased levels of noisy splicing in cancers, but not for oncogene-derived transcripts. Hum Mol Genet (2011) 0.85
Comprehensive in silico functional specification of mouse retina transcripts. BMC Genomics (2005) 0.85
HEXEvent: a database of Human EXon splicing Events. Nucleic Acids Res (2012) 0.85
Computational detection and functional analysis of human tissue-specific A-to-I RNA editing. PLoS One (2011) 0.84
PELP1 oncogenic functions involve alternative splicing via PRMT6. Mol Oncol (2013) 0.84
Identification of a human TFPI-2 splice variant that is upregulated in human tumor tissues. Mol Cancer (2007) 0.83
Identifying alternative hyper-splicing signatures in MG-thymoma by exon arrays. PLoS One (2008) 0.83
Splice-mediated Variants of Proteins (SpliVaP) - data and characterization of changes in signatures among protein isoforms due to alternative splicing. BMC Genomics (2008) 0.82
In silico to in vivo splicing analysis using splicing code models. Methods (2013) 0.81
SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA. Oncol Rep (2013) 0.80
Refining orthologue groups at the transcript level. BMC Genomics (2010) 0.80
ASePCR: alternative splicing electronic RT-PCR in multiple tissues and organs. Nucleic Acids Res (2005) 0.80
PTEN transcript variants caused by illegitimate splicing in "aged" blood samples and EBV-transformed cell lines. Hum Genet (2010) 0.80
A study of alternative splicing in the pig. BMC Res Notes (2010) 0.79
Full-length single-cell RNA-seq applied to a viral human cancer: applications to HPV expression and splicing analysis in HeLa S3 cells. Gigascience (2015) 0.79
A phylogenetic generalized hidden Markov model for predicting alternatively spliced exons. Algorithms Mol Biol (2006) 0.78
Identification of novel splice variants and exons of human endothelial cell-specific chemotaxic regulator (ECSCR) by bioinformatics analysis. Comput Biol Chem (2012) 0.78
Potential molecular targeting of splice variants for cancer treatment. Indian J Exp Biol (2011) 0.78
Signs of positive selection of somatic mutations in human cancers detected by EST sequence analysis. BMC Cancer (2006) 0.78
Identification of tumor-associated cassette exons in human cancer through EST-based computational prediction and experimental validation. Mol Cancer (2010) 0.78
Meta-analytical biomarker search of EST expression data reveals three differentially expressed candidates. BMC Genomics (2012) 0.78
Coupling between alternative polyadenylation and alternative splicing is limited to terminal introns. RNA Biol (2016) 0.77
Splicing predictions reliably classify different types of alternative splicing. RNA (2015) 0.77
Alternative splicing and the evolution of phenotypic novelty. Philos Trans R Soc Lond B Biol Sci (2017) 0.76
Isolation and characterization of novel RECK tumor suppressor gene splice variants. Oncotarget (2015) 0.76
The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression. Mol Cell Oncol (2014) 0.75
"Dicing and Splicing" Sphingosine Kinase and Relevance to Cancer. Int J Mol Sci (2017) 0.75
Targeting alternatively spliced sequence features for cancer diagnosis and therapeutics. J Gastroenterol (2005) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet (2000) 24.22
Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci U S A (2002) 10.28
Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res (2001) 7.27
Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Res (2002) 6.71
Frequent alternative splicing of human genes. Genome Res (1999) 6.68
Gene structure prediction and alternative splicing analysis using genomically aligned ESTs. Genome Res (2001) 5.38
EST comparison indicates 38% of human mRNAs contain possible alternative splice forms. FEBS Lett (2000) 4.96
Selecting for functional alternative splices in ESTs. Genome Res (2002) 2.90
Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. Cancer Res (2003) 2.84
CD44 in cancer. Crit Rev Clin Lab Sci (2002) 2.83
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res (1995) 2.67
ISIS, the intron information system, reveals the high frequency of alternative splicing in the human genome. Nat Genet (2000) 2.64
Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J Biol Chem (1999) 1.91
Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc Natl Acad Sci U S A (1999) 1.68
Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors. Cancer Res (2001) 1.66
Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Mol Cell (2002) 1.58
Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci U S A (1994) 1.39
Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2. Mol Endocrinol (1999) 1.36
Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis. Breast Cancer Res Treat (1999) 1.27
An alternatively spliced cadherin-11 enhances human breast cancer cell invasion. Cancer Res (2002) 1.26
The role of diethylstilbestrol in the treatment of prostate cancer. Urology (2001) 1.25
Modulation of aromatase expression in the breast tissue by ERR alpha-1 orphan receptor. Cancer Res (1998) 1.15
Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin. Am J Pathol (2002) 1.12
Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer. Cancer Res (2002) 1.08
Alternatively spliced products CC3 and TC3 have opposing effects on apoptosis. Mol Cell Biol (2000) 1.05
Spontaneous frequency of exon skipping in the human HPRT gene. Mutat Res (2002) 1.00
Molecular basis for the constitutive activity of estrogen-related receptor alpha-1. J Biol Chem (2001) 0.97
NABC1 (BCAS1): alternative splicing and downregulation in colorectal tumors. Genomics (2000) 0.96
The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis. Blood (2002) 0.93
Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro. Cancer Res (1987) 0.92
5'-End RET splicing: absence of variants in normal tissues and intron retention in pheochromocytomas. Oncology (2002) 0.92
Redundant intronic repressors function to inhibit fibroblast growth factor receptor-1 alpha-exon recognition in glioblastoma cells. J Biol Chem (1999) 0.91
Identification of alternatively spliced Act1 and implications for its roles in oncogenesis. Biochem Biophys Res Commun (2002) 0.88
Brn-3a, a neuronal transcription factor of the POU gene family: indications for its involvement in cancer and angiogenesis. Mol Biotechnol (2002) 0.86
Frequent association of alternative splicing of NER, a nuclear hormone receptor gene in cancer tissues. Oncogene (1997) 0.85
New splicing variants for human Tyrosine Hydroxylase gene with possible implications for the detection of minimal residual disease in patients with neuroblastoma. Neurosci Lett (2003) 0.84
A genomic view of alternative splicing. Nat Genet (2002) 12.62
Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Res (2002) 6.71
Combining partial order alignment and progressive multiple sequence alignment increases alignment speed and scalability to very large alignment problems. Bioinformatics (2004) 3.83
Alternative splicing and RNA selection pressure--evolutionary consequences for eukaryotic genomes. Nat Rev Genet (2006) 3.00
Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J Virol (2008) 2.83
Assessing the impact of alternative splicing on domain interactions in the human proteome. J Proteome Res (2004) 2.71
Clinical correlates in an experimental model of repetitive mild brain injury. Ann Neurol (2013) 2.32
A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics (2009) 2.27
Detecting tissue-specific regulation of alternative splicing as a qualitative change in microarray data. Nucleic Acids Res (2004) 2.17
Global analysis of alternative splicing differences between humans and chimpanzees. Genes Dev (2007) 2.00
Inferring protein domain interactions from databases of interacting proteins. Genome Biol (2005) 1.97
Evidence for a subpopulation of conserved alternative splicing events under selection pressure for protein reading frame preservation. Nucleic Acids Res (2004) 1.93
Motor cortex organization after stroke is related to side of stroke and level of recovery. Stroke (2003) 1.91
An expectation-maximization algorithm for probabilistic reconstructions of full-length isoforms from splice graphs. Nucleic Acids Res (2006) 1.90
Evidence of functional selection pressure for alternative splicing events that accelerate evolution of protein subsequences. Proc Natl Acad Sci U S A (2005) 1.88
The ASAP II database: analysis and comparative genomics of alternative splicing in 15 animal species. Nucleic Acids Res (2006) 1.80
The multiassembly problem: reconstructing multiple transcript isoforms from EST fragment mixtures. Genome Res (2004) 1.70
Activated charcoal decreases the risk of QT prolongation after citalopram overdose. Ann Emerg Med (2007) 1.58
QPRIMER: a quick web-based application for designing conserved PCR primers from multigenome alignments. Bioinformatics (2007) 1.49
Molecular mechanism of AHSP-mediated stabilization of alpha-hemoglobin. Cell (2004) 1.39
Toxoplasmosis in HIV/AIDS patients: a current situation. Jpn J Infect Dis (2004) 1.37
Widespread production of novel soluble protein isoforms by alternative splicing removal of transmembrane anchoring domains. FEBS Lett (2003) 1.29
Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack normal splice forms. Nucleic Acids Res (2005) 1.23
Implementing the LIM code: the structural basis for cell type-specific assembly of LIM-homeodomain complexes. EMBO J (2008) 1.19
Role of self-care in the patient with heart failure. Curr Cardiol Rep (2012) 1.12
Dual-energy CT for the assessment of contrast material distribution in the pulmonary parenchyma. AJR Am J Roentgenol (2009) 1.11
Promoting healing and restoring trust: policy recommendations for improving behavioral health care for American Indian/Alaska Native adolescents. Am J Community Psychol (2010) 1.09
Lef1 haploinsufficient mice display a low turnover and low bone mass phenotype in a gender- and age-specific manner. PLoS One (2009) 1.08
The effect of intron length on exon creation ratios during the evolution of mammalian genomes. RNA (2008) 1.07
Distinguishing HIV-1 drug resistance, accessory, and viral fitness mutations using conditional selection pressure analysis of treated versus untreated patient samples. Biol Direct (2006) 1.06
Radiofrequency ablation of lung tumors: imaging features of the postablation zone. Radiographics (2012) 1.04
Pandemic response lessons from influenza H1N1 2009 in Asia. Respirology (2011) 1.03
Reconstruction of full-length isoforms from splice graphs. Methods Mol Biol (2008) 1.01
Surgical site infection following spinal instrumentation for scoliosis: a multicenter analysis of rates, risk factors, and pathogens. J Bone Joint Surg Am (2013) 1.01
Neuroimaging in pediatric epilepsy: a multimodality approach. Radiographics (2008) 1.00
The HIV positive selection mutation database. Nucleic Acids Res (2006) 0.99
National trends in emergency department antibiotic prescribing for children with acute otitis media, 1996 2005. Acad Emerg Med (2007) 0.98
Can RNA selection pressure distort the measurement of Ka/Ks? Gene (2006) 0.98
Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East Asia. J Acquir Immune Defic Syndr (2014) 0.97
MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration. FASEB J (2005) 0.96
Assessing the application of Ka/Ks ratio test to alternatively spliced exons. Bioinformatics (2005) 0.96
Heterosynaptic plasticity prevents runaway synaptic dynamics. J Neurosci (2013) 0.96
Distinguishing functional amino acid covariation from background linkage disequilibrium in HIV protease and reverse transcriptase. PLoS One (2007) 0.95
Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12. Proteins (2008) 0.95
1H, 15N and 13C assignments of an intramolecular Lhx3:ldb1 complex. J Biomol NMR (2005) 0.95
Background and methodology of MONITOR-GCSF, a pharmaco-epidemiological study of the multi-level determinants, predictors, and clinical outcomes of febrile neutropenia prophylaxis with biosimilar granulocyte-colony stimulating factor filgrastim. Crit Rev Oncol Hematol (2010) 0.94
Relating alternative splicing to proteome complexity and genome evolution. Adv Exp Med Biol (2007) 0.94
The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial. Hum Reprod (2010) 0.92
Percutaneous direct mitral annuloplasty using the Mitralign Bident system: description of the method and a case report. Kardiol Pol (2013) 0.92
Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancer. J Thorac Oncol (2012) 0.92
AIDS-related opportunistic infections in Hospital Kuala Lumpur. Jpn J Infect Dis (2003) 0.91
A statewide colectomy experience: the role of full bowel preparation in preventing surgical site infection. Ann Surg (2014) 0.90
Evidence of a novel RNA secondary structure in the coding region of HIV-1 pol gene. RNA (2008) 0.89
Necrotizing sarcoid granulomatosis. Curr Opin Pulm Med (2012) 0.89
The association between hypothermia, prehospital cooling, and mortality in burn victims. Acad Emerg Med (2010) 0.88
Tuberculosis in AIDS patients. Malays J Med Sci (2003) 0.88
Netherton syndrome and trichorrhexis invaginata--a novel diagnostic approach. Pediatr Dermatol (2008) 0.87
Detrimental effect of genetic inhibition of B-site APP-cleaving enzyme 1 on functional outcome after controlled cortical impact in young adult mice. J Neurotrauma (2011) 0.86
Developmentally regulated inhibition of cell cycle progression by glucocorticoids through repression of cyclin A transcription in primary osteoblast cultures. J Cell Physiol (2011) 0.86
What are the risks of prophylactic pinning to prevent contralateral slipped capital femoral epiphysis? Clin Orthop Relat Res (2013) 0.86
Prostaglandin E2 released from activated microglia enhances astrocyte proliferation in vitro. Toxicol Appl Pharmacol (2009) 0.85
Effectiveness of amlodipine-valsartan single-pill combinations: hierarchical modeling of blood pressure and total cardiovascular disease risk outcomes (the EXCELLENT study). Ann Pharmacother (2011) 0.85
Population-based comparison of two feeding tube approaches for head and neck cancer patients receiving concurrent systemic-radiation therapy: is a prophylactic feeding tube approach harmful or helpful? Support Care Cancer (2013) 0.85
Cortical adaptation following partial glossectomy with primary closure: implications for reconstruction of the oral tongue. Ann Otol Rhinol Laryngol (2005) 0.84
Successful medical management of a left ventricular thrombus and aneurysm following failed thrombolysis in myocardial infarction. Clin Med Insights Cardiol (2013) 0.84
A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study. Intern Emerg Med (2011) 0.84
Competition between LIM-binding domains. Biochem Soc Trans (2008) 0.84
A Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients. Cancer Invest (2007) 0.83
Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program. Vasc Health Risk Manag (2011) 0.83
POAVIZ: a Partial order multiple sequence alignment visualizer. Bioinformatics (2003) 0.83
Measurement and modeling of the effect of support arm backscatter on dosimetry with a varian EPID. Med Phys (2010) 0.83
Effect of MOG sensitization on somatosensory evoked potential in Lewis rats. J Neurol Sci (2009) 0.83
Yarn design for functional tissue engineering. J Biomech (2005) 0.82
Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study). Ann Pharmacother (2009) 0.82
How well does self-reported adherence fare compared to therapeutic drug monitoring in HAART? Prev Med (2013) 0.82
Citrobacter koseri bacteraemia complicated by paraspinal abscess and spondylodiscitis--a case report. Med J Malaysia (2012) 0.82
Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian Patients. PLoS One (2013) 0.81
Does preoperative rofecoxib (Vioxx) decrease postoperative pain with laparoscopic cholecystectomy? Am J Surg (2004) 0.81
An energy fluence-convolution model for amorphous silicon EPID dose prediction. Med Phys (2009) 0.80
Evolutionary divergence of exon flanks: a dissection of mutability and selection. Genetics (2006) 0.80
Modelling of blood pressure and total cardiovascular risk outcomes after second-line valsartan therapy: the BSCORE study. Arch Cardiovasc Dis (2011) 0.80
AIDS-defining illnesses: a comparison between before and after commencement of highly active antiretroviral therapy (HAART). Curr HIV Res (2007) 0.80
Incidental myocardial infarct on conventional nongated CT: a review of the spectrum of findings with gated CT and cardiac MRI correlation. AJR Am J Roentgenol (2012) 0.79
Bioinformatics detection of alternative splicing. Methods Mol Biol (2008) 0.79
Primary closure of cutaneous abscesses: a systematic review. Am J Emerg Med (2010) 0.79
Solution structure of the LIM-homeodomain transcription factor complex Lhx3/Ldb1 and the effects of a pituitary mutation on key Lhx3 interactions. PLoS One (2012) 0.79
Anomalous coronary arteries: cardiovascular computed tomographic angiography for surgical decisions and planning. World J Pediatr Congenit Heart Surg (2013) 0.78
The branched-chain aminotransferase proteins: novel redox chaperones for protein disulfide isomerase--implications in Alzheimer's disease. Antioxid Redox Signal (2013) 0.78
Concussive injury before or after controlled cortical impact exacerbates histopathology and functional outcome in a mixed traumatic brain injury model in mice. J Neurotrauma (2013) 0.78
An analysis of cancer-related alternative splicing through a genomics-based approach. Discov Med (2003) 0.78
Cardiac sarcoidosis: a review 2011. Curr Opin Pulm Med (2011) 0.78
Three-Dimensional Phylogeny Explorer: distinguishing paralogs, lateral transfer, and violation of "molecular clock" assumption with 3D visualization. BMC Bioinformatics (2007) 0.78
The economic cost of environmental factors among North Carolina children living in substandard housing. Am J Public Health (2009) 0.78
The redox switch that regulates molecular chaperones. Biomol Concepts (2015) 0.77
Reconstructing the age and historical biogeography of the ancient flowering-plant family Hydatellaceae (Nymphaeales). BMC Evol Biol (2014) 0.77
Thromboelastographic monitoring of the efficacy of recombinant factor VIIa administration in a parturient with factor VII deficiency. Can J Anaesth (2006) 0.77
Burns in the emergency department: a national perspective. J Emerg Med (2008) 0.76
Intensive care unit versus hospital floor: a comparative study of postoperative management of patients with adolescent idiopathic scoliosis. J Bone Joint Surg Am (2013) 0.76
Use of a SCID mouse model to select for a more aggressive strain of prostate cancer. Anticancer Res (2003) 0.76
Identifying language comprehension impairment in preschool children. Lang Speech Hear Serv Sch (2008) 0.76